AOD-9604 is marketed as a fat-loss fragment derived from growth hormone, positioned as lipolytic without GH side effects. What the evidence looks like: AOD-9604 has been studied in humans with a focus on safety/tolerability, including multiple randomized trials described in the literature
GROWTH HORMONE STRUCTURE This is a 191 amino acid single chain polypeptide hormone that occurs in various modified forms in the circulation
Notably, inflammation and endothelial dysfunction in the placenta have been proposed as two essential hallmarks of PE 6,7
Peptide identity and purity are verified by third-party labs using analytical techniques such as high performance liquid chromatography and complementary analytical methods, with Certificates of Analysis available for each batch What receptors does Cagrilintide interact with in experimental systems
Ong SWX, Fong SW, Young BE, Chan YH, Lee B, Amrun SN, et al